Simcor Dosage

The usual starting dosage of Simcor for most people is 500/20 mg once a day, taken at bedtime with a low-fat snack. If necessary, your healthcare provider may gradually increase your dose up to a maximum of 2000/40 mg daily. If you are switching from Niaspan, your healthcare provider may recommend that you start with a dose that is higher than normally recommended.

An Introduction to Simcor Dosing

The dosage of Simcor® (niacin extended-release/simvastatin) that your healthcare provider recommends will vary, depending on a number of factors, including:
 
As is always the case, do not adjust your dose unless your healthcare provider specifically instructs you to do so.
 

Simcor Dosage for High Cholesterol

The recommended starting Simcor dose for most people with
 high cholesterol is 500/20 mg once a day, taken at bedtime with a low-fat snack.
 
Your healthcare provider may increase your dose if necessary. This must be done slowly, to minimize liver problems as well as flushing due to the niacin component of the medication. It is recommended to increase the dose no more rapidly than by 500 mg (based on the niacin component) every four weeks. The dosage can also be decreased if Simcor side effects occur. The maximum recommended daily dosage of Simcor is 2000/40 mg (two 1000/20 mg tablets) once daily.
 
In order to minimize flushing, your healthcare provider may recommend taking aspirin or other similar nonsteroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen. This works best if you take the aspirin or NSAID about 30 minutes before your Simcor dose. Be sure to check with your healthcare provider first, since there may be a reason why you should not take aspirin or an NSAID.
 
There is no way to take less than 20 mg of the simvastatin component while taking Simcor, since the tablets cannot be split. Therefore, if a lower dosage is recommended in your particular situation, this medication is not a good choice for you.
 
(Simcor Dosage Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation